IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

Sweden · Delayed Price · Currency is SEK

1.268

+0.030 (2.42%)

At close: Jun 11, 2026

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	57.46M	94.63M	5.68M	61.14M	207.78M
Pharmaceuticals Growth	-39.28%	1566.57%	-90.71%	-70.58%	69160.67%
Total	57.46M	94.63M	5.68M	61.14M	207.78M
Total Growth	-39.28%	1566.57%	-90.71%	-70.58%	69160.67%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	57.46M	94.63M	4.22M	-	-
United States Growth	-39.28%	2142.37%	-	-	-
United Kingdom	-	-	1.46M	61.14M	207.78M
United Kingdom Growth	-	-	-97.62%	-70.58%	-
Total	57.46M	94.63M	5.68M	61.14M	207.78M
Total Growth	-39.28%	1566.57%	-90.71%	-70.58%	-

Source: S&P Global Market Intelligence.